Free Trial
NASDAQ:SEER

Seer Q1 2025 Earnings Report

Seer logo
$1.96 -0.01 (-0.51%)
Closing price 04/28/2025 04:00 PM Eastern
Extended Trading
$1.96 0.00 (0.00%)
As of 04/28/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Seer EPS Results

Actual EPS
N/A
Consensus EPS
-$0.37
Beat/Miss
N/A
One Year Ago EPS
N/A

Seer Revenue Results

Actual Revenue
N/A
Expected Revenue
$3.25 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Seer Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Tuesday, May 13, 2025
Conference Call Time
4:30PM ET

Conference Call Resources

Seer Earnings Headlines

Seer (NASDAQ:SEER) Shares Down 2.5% - Here's Why
Real Americans Don’t Wait on Wall Street’s Next Move
What's happening in the markets right now should concern every freedom-loving American who's worked hard and saved smart. Your 401(k) doesn't deserve to be dragged through the mud by tariffs, trade wars, reckless spending, and political standoffs. And you don't have to stand by while Wall Street plays roulette with your future.
See More Seer Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Seer? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Seer and other key companies, straight to your email.

About Seer

Seer (NASDAQ:SEER), a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

View Seer Profile

More Earnings Resources from MarketBeat